PI’s cutting-edge production plants ensure high quality, flexibility and that deadlines are adhered to for prototypes and for both small batches and large-scale production runs on automated production lines. The piezoelectric PICMA multilayer actuators are perfect for highly dynamic dosing tasks in the medical technology and biotechnology sector. They have an all-ceramic layer of insulation and are protected against moisture, which means that they have an extremely long life. Therefore, they offer a higher level of reliability, even under extreme environmental conditions. Due to their low operating voltage and their capacity to generate high forces, PICMA actuators are used in a variety of medical pumping and dosing applications, such as precision dosing and cell sorting. Piezoelectric elements for distributing and regulating small volumes in the milliliter to picoliter range have made liquid handling applications in in-vitro diagnostics and automation applications in laboratories, such as polymerase chain reaction or sequencing the entire genome, possible. Miniaturized PICMA chip actuators enable droplets to be formed quickly and precisely on even the smallest areas.
Biosensors for multiparametric measurements
Even though the fight against the current Coronavirus will be a significant topic at virtual.COMPAMED 2020, the event will also cover a diverse range of topics. Biosensors have been a subject of much interest in intensive care medicine and management of diabetes for many years. Jobst Technologies, which belongs to the Swiss sensor manufacturer Innovative Sensor Technology (IST), will present a biosensor that is capable of measuring glucose, lactate, glutamine and glutamate simultaneously, even in complex mixtures such as whole blood. “Our sensors prove a high stability in operation. Especially the continuous lactate measurement, which we have been able to realize exclusively up to now, makes the use in intensive care medicine possible,” said Gerhard Jobst, founder and CEO of Jobst Technologies.
The biosensors employ the enzymatic-amperometric measurement principle. They use immobilized enzymes in order to detect the target analytes with a high level of specificity and reliability. The flow-through biosensor can analyze glucose and lactate levels from 48 samples per hour or monitor them continuously, as does the first glucose and lactate monitor for critically ill patients. Jobst Technologies will present its biosensor and microfluidic portfolio together with IST's physical and chemical sensors at virtual.COMPAMED.
